Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)

ClinicalTrials.gov ID: NCT04068051

Public ClinicalTrials.gov record NCT04068051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Long-Term Study to Assess the Safety and Efficacy of AXS-07 (MoSEIC™ Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

MOVEMENT (Multimechanistic Treatment over Time of Migraine Symptoms) is a Phase 3 study to evaluate the long-term safety of chronic intermittent use of AXS-07 and to assess the effect of AXS-07 on migraine symptoms following repeated treatment of migraine attacks.

Study identification

NCT ID
NCT04068051
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
706 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2019 (Actual)
Primary completion
Sep 22, 2020 (Actual)
Completion
Sep 22, 2020 (Actual)
Last update posted
Oct 10, 2023

2019 – 2020

United States locations

U.S. sites
51
U.S. states
25
U.S. cities
49
Facility City State ZIP Site status
Clinical Research Site Birmingham Alabama 32516 —
Clinical Research Site Birmingham Alabama 32542 —
Clinical Research Site Mobile Alabama 36608 —
Clinical Research Site Phoenix Arizona 85004 —
Clinical Research Site Canoga Park California 91303 —
Clinical Research Site Colton California 92324 —
Clinical Research Site Encino California 91316 —
Clinical Research Site Los Alamitos California 90720 —
Clinical Research Site Los Angeles California 90017 —
Clinical Research Site Los Angeles California 90048 —
Clinical Research Site San Diego California 92103 —
Clinical Research Site Spring Valley California 91978 —
Clinical Research Site Walnut Creek California 94598 —
Clinical Research Site Hallandale Florida 33009 —
Clinical Research Site Jacksonville Florida 32256 —
Clinical Research Site Lake City Florida 32055 —
Clinical Research Site Lake Worth Florida 33467 —
Clinical Research Site Miami Florida 33155 —
Clinical Research Site Ocoee Florida 34761 —
Clinical Research Site Orlando Florida 32801 —
Clinical Research Site Ormond Beach Florida 32174 —
Clinical Research Site Tampa Florida 33634 —
Clinical Research Site Stockbridge Georgia 30281 —
Clinical Research Site Evanston Illinois 60201 —
Clinical Research Site Louisville Kentucky 40213 —
Clinical Research Site Boston Massachusetts 02131 —
Clinical Research Site North Dartmouth Massachusetts 02747 —
Clinical Research Site Waltham Massachusetts 02451 —
Clinical Research Site Ann Arbor Michigan 48104 —
Clinical Research Site Minneapolis Minnesota 55402 —
Clinical Research Site Springfield Missouri 65810 —
Clinical Research Site Las Vegas Nevada 89102 —
Clinical Research Site Albuquerque New Mexico 87102 —
Clinical Research Site Manlius New York 13104 —
Clinical Research Site Rochester New York 14609 —
Clinical Research Site Williamsville New York 14221 —
Clinical Research Site High Point North Carolina 27262 —
Clinical Research Site Cincinnati Ohio 45212 —
Clinical Research Site Columbus Ohio 43213 —
Clinical Research Site Oklahoma City Oklahoma 73106 —
Clinical Research Site Portland Oregon 97214 —
Clinical Research Site Salem Oregon 97301 —
Clinical Research Site Philadelphia Pennsylvania 19114 —
Clinical Research Site Charleston South Carolina 29406 —
Clinical Research Site Mt. Pleasant South Carolina 29464 —
Clinical Research Site Knoxville Tennessee 37920 —
Clinical Research Site Memphis Tennessee 38119 —
Clinical Research Site Austin Texas 78731 —
Clinical Research Site Salt Lake City Utah 84107 —
Clinical Research Site Charlottesville Virginia 22911 —
Clinical Research Site Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04068051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04068051 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →